Search research articles
Contact Us
Filters
Showing results (161-170 of 177) with videos related to
Page
of 18
Sort By:
Molecular Cancer
|
November 23, 2012
Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system
Zhen-Lin Nie, Yu-Qin Pan, Bang-Shun He, et al.
Frontiers in Immunology
|
August 7, 2023
Selenomethionine against titanium particle-induced osteolysis by regulating the ROS-dependent NLRP3 inflammasome activation via the β-catenin signaling pathway
Ruixuan Yu, Yongjian Yuan, Zhicheng Liu, et al.
Pain
|
January 11, 2017
Epigenetic upregulation of CXCL12 expression mediates antitubulin chemotherapeutics-induced neuropathic pain
Ting Xu, Xiao-Long Zhang, Han-Dong Ou-Yang, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
November 6, 2023
Temperature-Dependent Color-Tunable Afterglow in Zirconium-Doped CsCdCl<sub>3</sub> Perovskite for Advanced Anti-Counterfeiting and Thermal Distribution Detection
Xuanyu Zhu, Tingxiang Gu, Lei Zhao, et al.
Cancer Research
|
March 11, 2010
An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation
Birgit Schoeberl, Anthony C Faber, Danan Li, et al.
Ebiomedicine
|
September 29, 2024
Association of mixed exposure to microplastics with sperm dysfunction: a multi-site study in China
Chen Zhang, Guanghui Zhang, Kuan Sun, et al.
Diabetes, Obesity & Metabolism
|
October 27, 2025
Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023-2024
Wenjia Yang, Xiaoling Cai, Qiuhe Ji, et al.
Science Signaling
|
July 2, 2009
Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis
Birgit Schoeberl, Emily A Pace, Jonathan B Fitzgerald, et al.
Stem Cell Research & Therapy
|
November 5, 2025
CXCR5-engineered mesenchymal stromal cells home to spleen and mitigate post-sepsis syndrome by preventing secondary infection
Jiahao Shi, Lu Zhu, Xin Sui, et al.
Cell Death & Disease
|
January 25, 2019
ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7
Ting Guo, Xian-Zi Wen, Zi-Yu Li, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 177) with videos related to
Sort By:
Page
of 18
Molecular Cancer
|
November 23, 2012
Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system
Zhen-Lin Nie, Yu-Qin Pan, Bang-Shun He, et al.
Frontiers in Immunology
|
August 7, 2023
Selenomethionine against titanium particle-induced osteolysis by regulating the ROS-dependent NLRP3 inflammasome activation via the β-catenin signaling pathway
Ruixuan Yu, Yongjian Yuan, Zhicheng Liu, et al.
Pain
|
January 11, 2017
Epigenetic upregulation of CXCL12 expression mediates antitubulin chemotherapeutics-induced neuropathic pain
Ting Xu, Xiao-Long Zhang, Han-Dong Ou-Yang, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
November 6, 2023
Temperature-Dependent Color-Tunable Afterglow in Zirconium-Doped CsCdCl<sub>3</sub> Perovskite for Advanced Anti-Counterfeiting and Thermal Distribution Detection
Xuanyu Zhu, Tingxiang Gu, Lei Zhao, et al.
Cancer Research
|
March 11, 2010
An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation
Birgit Schoeberl, Anthony C Faber, Danan Li, et al.
Ebiomedicine
|
September 29, 2024
Association of mixed exposure to microplastics with sperm dysfunction: a multi-site study in China
Chen Zhang, Guanghui Zhang, Kuan Sun, et al.
Diabetes, Obesity & Metabolism
|
October 27, 2025
Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023-2024
Wenjia Yang, Xiaoling Cai, Qiuhe Ji, et al.
Science Signaling
|
July 2, 2009
Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis
Birgit Schoeberl, Emily A Pace, Jonathan B Fitzgerald, et al.
Stem Cell Research & Therapy
|
November 5, 2025
CXCR5-engineered mesenchymal stromal cells home to spleen and mitigate post-sepsis syndrome by preventing secondary infection
Jiahao Shi, Lu Zhu, Xin Sui, et al.
Cell Death & Disease
|
January 25, 2019
ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7
Ting Guo, Xian-Zi Wen, Zi-Yu Li, et al.
Page
of 18